Trending
- Biomarker-Independent ADC Rina-S Advances to Phase 3 in Endometrial Cancer
- Rewriting the Prescription: Can Exercise Optimize Treatment Outcomes in Oncology?
- Adaptive Planning Trial Aims to Improve Radiosurgery Precision in Brain Metastases
- Decitabine suppresses triple-negative breast cancer by disrupting DNMT1 liquid-liquid phase separation and synergizes with G9a inhibition
- FDA gives expedited approval to new groundbreaking pancreatic cancer drug | US news
- FDA Approves Landmark Pancreatic Cancer Drug That’s Shown to Improve Survival
- Debate: CAR-T Cell Therapy Versus BCMA Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma
- FDA Approves Daraxonrasib for Previously Treated Metastatic Pancreatic Cancer
